These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12066521)

  • 1. [ACE inhibition in tissues. Decisive for prognosis?].
    MMW Fortschr Med; 2002 Mar; 144(11):60. PubMed ID: 12066521
    [No Abstract]   [Full Text] [Related]  

  • 2. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardioprotection through ACE inhibition. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 26 May 1988, Kyoto, Japan].
    Fortschr Med Suppl; 1988; 51():1-17. PubMed ID: 2904397
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACE inhibitors from the viewpoint of the clinical pharmacologist].
    Hitzenberger G
    Wien Med Wochenschr; 1996; 146(11):225-7. PubMed ID: 8928519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A difficult choice of ACE inhibitors].
    Tikkanen I
    Duodecim; 1993; 109(20):1805-11. PubMed ID: 7737003
    [No Abstract]   [Full Text] [Related]  

  • 6. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy and blood lipids: ACE inhibitors.
    Agner E
    Scand J Clin Lab Invest Suppl; 1990; 199():55-9. PubMed ID: 2191418
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit most.
    Asselbergs FW; van Gilst WH
    Curr Opin Cardiol; 2007 Jul; 22(4):267-72. PubMed ID: 17556876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ACE inhibitor therapy in treating cardiovascular disease.
    Flint L
    Nurs Times; 2004 Mar 23-29; 100(12):34-7. PubMed ID: 15067910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do ACE inhibitors decrease mortality in patients with hypertension?
    Neher JO
    Am Fam Physician; 2004 Jul; 70(1):153-4. PubMed ID: 15259531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is differentiation of ACE inhibitors based on their effects on the brain possible?].
    Unger T
    Fortschr Med; 1994 Dec; 112(34):504-6. PubMed ID: 7843678
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasopeptidases and their inhibitors].
    Agostoni A
    Recenti Prog Med; 2002 Oct; 93(10):519-22. PubMed ID: 12405010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with ACE inhibitors. What kind of risk make them indispensible?].
    Kleber FX
    MMW Fortschr Med; 2000 Nov; 142(46):44-5. PubMed ID: 11132312
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.